Handok to introduce calfactant, acute respiratory distress syndrome treatment

Handok Pharm says it signed a licensing agreement with the US-based Pneuma Partners to distribute calfactant (trade name: Infasurf), a medication used to treat respiratory distress syndrome (RDS), a lung condition that can occur in prematurely born infants whose lungs have not completely developed.

Approved by the US Food and Drug Administration in July 1998, Infasurf is an extract of a natu...